BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,532,000 | -27.7% | 154,634 | -41.2% | 1.31% | -5.2% |
| Q1 2022 | $31,171,000 | -13.2% | 262,890 | +0.9% | 1.38% | +8.8% |
| Q4 2021 | $35,911,000 | +14.7% | 260,582 | +15.6% | 1.27% | +16.8% |
| Q3 2021 | $31,310,000 | +379.8% | 225,401 | +196.1% | 1.08% | +377.5% |
| Q4 2020 | $6,525,000 | -46.0% | 76,124 | -59.0% | 0.23% | -57.6% |
| Q3 2020 | $12,083,000 | -62.4% | 185,864 | -57.7% | 0.54% | -64.6% |
| Q2 2020 | $32,106,000 | +84.1% | 439,148 | -14.3% | 1.52% | +38.7% |
| Q1 2020 | $17,437,000 | -30.2% | 512,399 | +11.7% | 1.09% | +7.2% |
| Q4 2019 | $24,967,000 | +96.5% | 458,609 | +50.6% | 1.02% | +81.2% |
| Q3 2019 | $12,708,000 | -5.2% | 304,604 | -0.5% | 0.56% | +5.8% |
| Q2 2019 | $13,402,000 | -47.7% | 306,042 | -38.5% | 0.53% | -48.2% |
| Q1 2019 | $25,618,000 | +44.2% | 497,721 | +3.6% | 1.03% | +23.7% |
| Q4 2018 | $17,762,000 | +0.9% | 480,318 | +2.4% | 0.83% | +39.5% |
| Q3 2018 | $17,607,000 | +28.8% | 468,893 | +35.6% | 0.60% | +20.2% |
| Q2 2018 | $13,666,000 | +62.4% | 345,790 | +5.9% | 0.50% | +50.0% |
| Q1 2018 | $8,413,000 | +10.0% | 326,607 | +15.2% | 0.33% | +8.6% |
| Q4 2017 | $7,649,000 | +2.2% | 283,498 | +41.6% | 0.30% | -2.6% |
| Q3 2017 | $7,483,000 | -15.1% | 200,186 | -43.2% | 0.31% | -18.8% |
| Q2 2017 | $8,814,000 | – | 352,560 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |